Table 3.
Disease type | Symptoms | Sweat chloridea | IRT | CFTR mutation class | Pancreatic status | FTT | Colonizationb |
---|---|---|---|---|---|---|---|
CF | + | Majority >60 mmol/l | ↑ | I–IIIc | >80% insufficient | >25% | >80% PA > 20% MRSA |
CFTR-RD | + | Majority <60 mmol/l | ↑ | IV–V | Sufficient | ~20% | <35% PA 0% MRSA |
CRMS | − | All <60 mmol/l | ↑ | IV–V | Sufficient | ~2% | <40% PA < 5% MRSA |
CF, cystic fibrosis; CFTR-RD, cystic fibrosis transmembrane regulator-related disease; CRMS, cystic fibrosis transmembrane regulator-related metabolic syndrome; FTT, failure to thrive; IRT, immunoreactive trypsinogen; MRSA, methicillin-resistant Staphylococcus aureus; PA, Pseudomonas aeruginosa.
Sweat chloride measurements are report.
Microbiological growth on oropharyngeal, sputum, and/or bronchoalveolar lavage specimens from the time poinst closest to diagnosis.
Exceptions noted in manuscript text.